50428-14-3 (硝苯地平亚硝基苯吡啶同系物,Dehydronitroso Nifedipine)

硝苯地平亚硝基苯吡啶同系物;4-(2-亚硝基苯基)-2,6-二甲基吡啶-3,5-二羧酸二甲基酯;Dehydronitroso硝苯地平;去氢亚硝基硝苯地平;硝苯地平杂质Ⅱ;硝苯地平杂质B;硝苯地平杂质B EP标准品;硝苯地平杂质B(EP) 标准品;

Nifedipine Nitrosophenylpyridine Analog;2,6-NTP;DNPDC;Dehydronitroso Nifedipine;Dimethyl 2,6-dimethyl-4-(2-nitrosophenyl)-3,5-pyridinedicarboxylate;dimethyl 2,6-dimethyl-4-(2-nitrosophenyl)pyridine-3,5-dicarboxylate;Nifedipine impurity B;4-(2-Nitrosophenyl)-2,6-dimethyl-3,5-dimethoxycarbonylpyridine;A899730;SCHEMBL744281;Dimethyl-2,6-Dimethyl-4-(2-Nitrosophenyl) Pyridine-3,5-Dicarboxylate;DTXSID50198466;nitrosonifedipine;23N9NLY17F;Nifedipine Imp. B (EP); Nifedipine Nitrosophenylpyridine Analog; Dimethyl 2,6-Dimethyl-4-(2-nitrosophenyl)pyridine-3,5-dicarboxylate; Nitrosophenylpyridine Analogue of Nifedipine; Nifedipine Impurity B;NIFEDIPINE IMPURITY B [EP IMPURITY];2,6-Dimethyl-4-(2'-nitrosophenyl)-3,5-pyridinedicarboxylic acid dimethyl ester;3,5-Pyridinedicarboxylic acid, 2,6-dimethyl-4-(2-nitrosophenyl)-, dimethyl ester;2,6-dimethyl-3,5-dimethoxycarbonyl-4-(2-nitrosophenyl)pyridine;FT-0665631;AS-82953;DehydronitrosoNifedipine;3,5-PYRIDINEDICARBOXYLIC ACID, 2,6-DIMETHYL-4-(2-NITROSOPHENYL)-, 3,5-DIMETHYL ESTER;Nifedipine impurity B, European Pharmacopoeia (EP) Reference Standard;NIFEDIPINE MAJOR DEGRADANT;F19299;50428-14-3;UNII-23N9NLY17F;Dimethyl 2,6-Dimethyl-4-(2-nitrosophenyl)pyridine-3,5-dicarboxylate (Nitrosophenylpyridine Analogue of Nifedipine);DS-017269;STL450974;

MFCD22572715

MUZLTKGYFZENFW-UHFFFAOYSA-N

1S/C17H16N2O5/c1-9-13(16(20)23-3)15(11-7-5-6-8-12(11)19-22)14(10(2)18-9)17(21)24-4/h5-8H,1-4H3

O(C)C(C1C(C)=NC(C)=C(C(=O)OC)C=1C1C=CC=CC=1N=O)=O

2933399090